Effect of pre-analytical variables on coagulation tests in hepatitis B patients

Jinmei Yao1, Guocai Lv

  • 1Department of Laboratory Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

To determine the effects of various pre-analytical variables on the values of activated partial thromboplastin time (APTT), D-dimers, fibrinogen (Fbg), prothrombin time (PT) and thrombin time (TT). Samples from 120 hepatitis B patients were divided into three groups based on storage time (0-24 h), mechanical agitation and separation into plasma. In all groups, samples were stored at room temperature and 4°C. The percentage changes compared to the baseline were calculated. Clinically relevant differences were defined as a more than 10% change. If less than 25% samples showed relevant differences, the effect of the pre-analytical variable was considered moderate; if more than 25% of samples showed relevant differences, the effect was deemed large. Clinically relevant differences in APTT were found in separated samples stored for 24 h. No relevant differences were seen in the other test results. All tested pre-analytical variables had a moderate effect on the D-dimer, Fbg, PT and TT values. Storage for 24 h had a large effect on APTT. Coagulation test results were unaffected by temperature, storage time, mechanical agitation and sample separation. Specimens for D-dimer, Fbg, PT and TT tests could be stored for 24 h, and specimens for APTT could be stored for 8 h.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K